Navidea Biopharmaceuticals, Inc. Press Releases

NAVB 
$1.8
*  
0.02
1.12%
Get NAVB Alerts
*Delayed - data as of Aug. 27, 2015  -  Find a broker to begin trading NAVB now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Navidea Biopharmaceuticals to Present at Sidoti Emerging Growth Conference
8/25/2015 7:30:00 AM - Business Wire
▲10.43 % Price Change since this news event. The Volume Ratio is 1.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals to Register Shares for Dual Listing on Tel-Aviv Stock Exchange
8/24/2015 7:30:00 AM - Business Wire
▲8.43 % Price Change since this news event. The Volume Ratio is 2.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Reports Publication of Lymphoseek® Comparative Results in Injection Site Pain Study in Breast Cancer
8/20/2015 7:30:00 AM - Business Wire
▲8.43 % Price Change since this news event. The Volume Ratio is 1.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek® Revenue Guidance
7/30/2015 7:30:00 AM - Business Wire
▲0.56 % Price Change since this news event. The Volume Ratio is 2.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Awarded $1.7 Million Fast Track NIH SBIR Grant for Evaluation of Manocept™ in Rheumatoid Arthritis
7/29/2015 7:30:00 AM - Business Wire
▲4.65 % Price Change since this news event. The Volume Ratio is 0.95.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant
7/28/2015 7:30:00 AM - Business Wire
▲2.86 % Price Change since this news event. The Volume Ratio is 1.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Verification of Lymphoseek® Mechanism of Action Published in Journal of Immunology
7/23/2015 8:50:00 AM - Business Wire
▲1.69 % Price Change since this news event. The Volume Ratio is 3.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals to Announce Second Quarter 2015 Financial Results on July 30, 2015
7/22/2015 3:56:00 PM - Business Wire
▲2.27 % Price Change since this news event. The Volume Ratio is 1.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals Announces 2015 Annual Meeting Results
7/16/2015 5:16:00 PM - Business Wire
▲2.27 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast / Call
7/7/2015 7:30:00 AM - Business Wire
▲5.88 % Price Change since this news event. The Volume Ratio is 1.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast
7/2/2015 6:12:00 PM - Business Wire
▲7.14 % Price Change since this news event. The Volume Ratio is 1.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Macrophage Therapeutics Reports Data Demonstrating a Manocept™ Drug Conjugate Induces Apoptosis in CD206 Positive Kaposi’s Sarcoma and Tumor Associated Macrophages
7/2/2015 7:45:00 AM - Business Wire
▲11.11 % Price Change since this news event. The Volume Ratio is 3.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Reports Clinical Data Demonstrating Manocept™ Agent Localizes in Multiple KS Lesions
7/2/2015 7:30:00 AM - Business Wire
▲11.11 % Price Change since this news event. The Volume Ratio is 3.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals to Present at JMP Life Sciences Conference
6/17/2015 9:11:00 AM - Business Wire
▲17.65 % Price Change since this news event. The Volume Ratio is 1.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Macrophage Therapeutics to Present at BIO2015 Conference
6/15/2015 7:30:00 AM - Business Wire
▲19.21 % Price Change since this news event. The Volume Ratio is 0.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BIND Therapeutics and Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin™ Nanoparticle Using Manocept™ Macrophage Targeting Platform
6/11/2015 8:00:00 AM - Business Wire
▲23.29 % Price Change since this news event. The Volume Ratio is 1.42.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Reports Manocept™ Study Results in Rheumatoid Arthritis Presented at EULAR 2015 European Congress of Rheumatology
6/11/2015 7:30:00 AM - Business Wire
▲23.29 % Price Change since this news event. The Volume Ratio is 1.42.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Reports Positive Lymphoseek® Comparative Results in Injection Site Pain Study in Breast Cancer
6/8/2015 4:30:00 PM - Business Wire
▲26.76 % Price Change since this news event. The Volume Ratio is 2.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea to Report Manocept™ Results in Kaposi’s Sarcoma at the International Workshop on KSHV and Related Agents
6/4/2015 12:51:00 PM - Business Wire
▲23.29 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Navidea Biopharmaceuticals Appoints Anton Gueth to Board of Directors
6/4/2015 7:30:00 AM - Business Wire
▲20.81 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day